Jonathan Silberstein MD, MBA
Chief of Urologic Oncology, Memorial Health System, Broward, FloridaBiographical Sketch:
Jonathan Silberstein earned his medical degree at SUNY Upstate Medical University in Syracuse, New York. He completed his general surgery internship and his urology residency at the University of California in San Diego. Following his residency, Dr. Silberstein completed a 3-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York. He joined the faculty of Tulane University School of Medicine in 2013 and was the Director of Urologic Oncology at Tulane and the Assistant Chief of Urology at the Southeast Louisiana Veterans Affairs Hospital. He is the author of more than 60 peer-reviewed publications and several book chapters.He is now the Chief of Urologic Oncology Memorial Health System, Broward Florida.
He is also the winner of numerous awards from national and international meetings and is a reviewer for several prominent urologic journals.
Positions:
Assistant Professor of Urology; Chief, Section of Urologic Oncology, Department of Urology, Tulane University School of Medicine; Chief of Urology Service, Department of Surgery, Southeast Louisiana Veterans Health Care Center, New Orleans, Louisiana
Degrees:
MD: SUNY Upstate Medical University, Syracuse, New York
Postgraduate Training:
Fellowship (urologic oncology): Memorial Sloan Kettering Cancer Center, New York, New York
Clinical Interests:
Advanced urologic malignancies
Research Interests:
Clinical trial design and implementation, 3D printing physical models of urologic malignancies
Recent Contributions to PracticeUpdate:
- Abiraterone Acetate Plus Prednisone in Black and White Men With Metastatic Castrate-Resistant Prostate Cancer
- Use of a 3D Model During Minimally Invasive Partial Nephrectomy Minimizes the Impairment of Kidney Function
- FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
- 2020 Top Stories in Advanced Prostate Cancer: Relugolix for Androgen-Deprivation Therapy
- Outcomes of Black Men With Prostate Cancer Treated With Radiation Therapy
- ASCO 2020: Abstract Recommendations From Dr. Jonathan Silberstein for Advanced Prostate Cancer
- Prostate Cancer in the COVID Era: Systemic Therapy for mCRPC
- Prostate Cancer in the COVID Era: Metastatic Hormone-Sensitive Prostate Cancer
- Prostate Cancer in the COVID-19 Era: Localized Prostate Cancer
- Chemotherapy After Prostatectomy for High-Risk Prostate Carcinoma